Food and Drugs Administration reject use of Ampligen for people with chronic fatigue syndrome

The US Federal Food and Drugs Administration has refused to approve the use of the experimental drug Ampligen in patients with chronic fatigue syndrome. To read an account of the ruling and its effect on manufacturer Hemispherx BioPharma on website, click here.


0344 576 5326

Available every day of the week between these times: 10am - 12noon, 2pm - 4pm and 7pm - 9pm.

Calls cost the same as other standard landline numbers (starting 01 or 02). If you have a call package for your landline or mobile phone then calls will normally come out of your inclusive minutes.